镰状细胞病青少年在COVID-19疫情前后于诊所就诊时的流感疫苗接种率
研究比较了2019-2020和2022-2023流感季在镰状细胞病(SCD)提供者诊所就诊的SCD青少年的流感疫苗接种率,并描述了感染特征。2019-2020季接种率为85%(n=220),2022-2023季为75%(n=245),差异未达统计学显著(p=0.059)。两个流感季均就诊的参与者更可能从2019-2020季接种转为2022-2023季未接种(McNemar's OR=3.0;p=0.008)。66例记录感染中25.8%导致住院。
要点
- 2019-2020季流感疫苗接种率为85%(n=220),2022-2023季为75%(n=245),p=0.059。
- 两个流感季均就诊者更可能从接种转为未接种(McNemar's OR=3.0;p=0.008)。
- 66例记录感染中25.8%导致住院。
核心结论
- 研究发现流感疫苗接种率较高,但两个流感季均就诊的儿童更可能转为未接种。
- 需要更多研究来了解该人群的流感疫苗决策。
研究设计与样本
- 比较2019-2020和2022-2023流感季在镰状细胞病(SCD)提供者诊所就诊的SCD青少年的流感疫苗接种率,并描述感染特征。
主要发现
- 2019-2020季85%(n=220)的儿童接种了流感疫苗,2022-2023季为75%(n=245)(p=0.059)。
- 两个流感季均就诊的参与者更可能从2019-2020季接种转为2022-2023季未接种,而非相反(McNemar's OR=3.0;p=0.008)。
- 66例记录感染中,25.8%导致住院。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要更多研究来了解该人群的流感疫苗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Influenza vaccination is critical for children with sickle cell disease (SCD) due to risks of severe influenza infections. Despite declining influenza vaccination among children since the COVID-19 pandemic, less is known about influenza vaccine coverage among youth with SCD during this same period. We compared influenza vaccine uptake among youth with SCD seen by a SCD provider in clinic during the 2019-2020 and 2022-2023 influenza seasons and described infection characteristics. Overall, 85% (n = 220) of children received their influenza vaccine during 2019-2020 compared to 75% (n = 245) in 2022-2023 (p = 0.059). Participants seen during both seasons were more likely to shift from vaccinated in 2019-2020 to unvaccinated in 2022-2023 than vice versa (McNemar's OR = 3.0; p = 0.008). Among 66 documented infections, 25.8% resulted in hospitalization. We found high influenza vaccine uptake but those seen during both seasons were more likely to become unvaccinated. More research is needed to understand influenza vaccine decision-making in this population.
引用
- Walden J, Stanek JR, Young J, et al. Influenza vaccine uptake among youth with sickle cell disease who are seen in clinic before and after the COVID-19 pandemic. Vaccine. 2024. PMID: 39126828. doi:10.1016/j.vaccine.2024.126212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。